Hopp til hovedinnhold

Gastrointestinale komplikasjoner til diabetes

Sist revidert:
Sist revidert av:
Definisjon:
Gastrointestinale (GI) tilstander forårsaket av diabetes inkluderer gastroparese, intestinal enteropati og ikke-alkoholisk fettleversykdom
Forekomst:
Er ikke blant de hyppigste komplikasjoner til diabetes
Symptomer:
Diaré, forstoppelse og fekal inkontinens
Funn:
Få kliniske funn
Diagnostikk:
Avhenger av den underliggende tilstand
Behandling:
Avhenger av patofysiologien
  1. Careyva B, Stello B. Diabetes Mellitus: Management of Gastrointestinal Complications. Am Fam Physician. 2016;94(12):980-986. PubMed  
  2. Frieling T. Diabetic autonomic neuropathy of the gastrointestinal tract. UpToDate, last updated Aug 07, 2018. www.uptodate.com  
  3. Stein B, Everhart KK, Lacy BE. Gastroparesis: A review of current diagnosis and treatment options. Journal of Clinical Gastroenterology, August 2015 ; 49: 550-8. doi:10.1097/MCG.0000000000000320 DOI  
  4. Ebert EC. Gastrointestinal complications of diabetes mellitus. Dis Mon 2005; 51: 620-63. PubMed  
  5. Bharucha AE. Epidemiology and natural history of gastroparesis. Gastroenterol Clin North Am. 2015;44(1):9–19. PMID: 25667019 PubMed  
  6. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L; American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18–37. PMID: 23147521 PubMed  
  7. Galligan JJ, Vanner S. Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil 2005; 17: 643-53. PubMed  
  8. Hejazi RA, McCallum RW, et al. Prokinetics in diabeetic gastroparesis. Curr Gastroenterol Rep 2012; 14: 297-305. PubMed  
  9. Ramirez R, Stalcup P, Croft B, Darracq MA. Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department. Am J Emerg Med 2017. pmid:28320545 PubMed  
  10. Olausson EA, Storsrud S, Grundin H, et al. A Small Particle Size Diet Reduces Upper Gastrointestinal Symptoms in Patients With Diabetic Gastroparesis: A Randomized Controlled Trial. Am J Gastroenterol 2014 Jan 14.
  11. Anand C, Al-Juburi A, Familoni B, et al. Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers. Digestion 2007; 75: 83-9. PubMed  
  12. Boland BS, Edelman SV, Wolosin JD. Gastrointestinal complications of diabetes. Endocrinol Metab Clin North Am. 2013;42(4):809–832. PMID: 24286951 PubMed  
  13. Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65(8):1096–1108. PMID: 26856933 PubMed  
  14. Goodwin G. Type 1 Diabetes Mellitus and Celiac Disease: Distinct Autoimmune Disorders That Share Common Pathogenic Mechanisms. Horm Res Paediatr. 2019;92(5):285-292. PubMed  
  15. Zein CO, et al. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 2005; 100: 48-55. PubMed  
  16. Lee WG, Wells CI, McCall JL, Murphy R, Plank LD. Prevalence of diabetes in liver cirrhosis: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2019;35(6):e3157. PubMed  
  17. Creighton Mitchell T, McClain DA. Diabetes and hemochromatosis. Curr Diab Rep. 2014;14(5):488. PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim